Mechanistically, KDM5D inhibited E2F transcription factor 1 expression through H3K4me3 demethylation, thereby inhibiting FKBP Prolyl Isomerase 4 transcription and exerting anti-tumor and anti-metastasis effects in CRC [155]. The gene discussed is KDM5D; the disease is colorectal carcinoma.